The ODAC chronicles: part 1. My first ODAC experience.
Antonio J
AJ
Grillo-López
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval; D023381:Endpoint Determination; D005060:Europe; D006801:Humans; D016019:Survival Analysis; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents